Add to ORKGSpates’ address was largely an analysis of U.S. v. Regenerative Sciences, a recent decision in which the United States District Court of the District of Columbia held that a procedure using adult autologous stem cells should be regulated by the FDA, based on the rationale that it amounts to the use of a drug. A summary of the event is available here
The use of stem cells as medicines is a promising and upcoming area of research as they may be able ...
Regenerative medicine is a new and promising mode of therapy for patients who have limited or no oth...
This thesis paper entitled, Stem Cell Therapy: boon or bane? intends to provide a comprehensive stud...
Spates’ address was largely an analysis of U.S. v. Regenerative Sciences, a recent decision in which...
Two years ago, the U.S. Food and Drug Administration (FDA) filed a lawsuit in a federal district cou...
The Food and Drug Administration (FDA) has sought an injunction to prevent a US-based company from o...
the FDA have regulatory authority over adult autologous stem cell therapies? 21 CFR 1271 and the emp...
In sports medicine, adult stem cells are the subject of great interest. Several uses of stem cells a...
From the introduction: Just as slight variations between different sources of stem cells are crucial...
Stem cell-based regenerative therapies hold the potential to address a host of health concerns, part...
After Congress adopted the 21st Century Cures Act in 2016, giving the U.S. Food and Drug Administrat...
In 2012, an op-ed in The Wall Street Journal, “The FDA Wants to Regulate Your Cells,” criticized a r...
After the Supreme Court\u27s decision in Ass\u27n for Molecular Pathology v. Myriad Genetic\u27s, pr...
The phrase "bench-to-bedside" is commonly used to describe the translation of basic discoveries such...
The growing industry of unproven stem cell therapies has focused on using autologous cells in order ...
The use of stem cells as medicines is a promising and upcoming area of research as they may be able ...
Regenerative medicine is a new and promising mode of therapy for patients who have limited or no oth...
This thesis paper entitled, Stem Cell Therapy: boon or bane? intends to provide a comprehensive stud...
Spates’ address was largely an analysis of U.S. v. Regenerative Sciences, a recent decision in which...
Two years ago, the U.S. Food and Drug Administration (FDA) filed a lawsuit in a federal district cou...
The Food and Drug Administration (FDA) has sought an injunction to prevent a US-based company from o...
the FDA have regulatory authority over adult autologous stem cell therapies? 21 CFR 1271 and the emp...
In sports medicine, adult stem cells are the subject of great interest. Several uses of stem cells a...
From the introduction: Just as slight variations between different sources of stem cells are crucial...
Stem cell-based regenerative therapies hold the potential to address a host of health concerns, part...
After Congress adopted the 21st Century Cures Act in 2016, giving the U.S. Food and Drug Administrat...
In 2012, an op-ed in The Wall Street Journal, “The FDA Wants to Regulate Your Cells,” criticized a r...
After the Supreme Court\u27s decision in Ass\u27n for Molecular Pathology v. Myriad Genetic\u27s, pr...
The phrase "bench-to-bedside" is commonly used to describe the translation of basic discoveries such...
The growing industry of unproven stem cell therapies has focused on using autologous cells in order ...
The use of stem cells as medicines is a promising and upcoming area of research as they may be able ...
Regenerative medicine is a new and promising mode of therapy for patients who have limited or no oth...
This thesis paper entitled, Stem Cell Therapy: boon or bane? intends to provide a comprehensive stud...